228
Views
9
CrossRef citations to date
0
Altmetric
Esophagus

Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma

, , , , , & show all
Pages 1422-1428 | Received 10 Jun 2012, Accepted 13 Aug 2012, Published online: 07 Sep 2012

References

  • Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049–53.
  • Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510–13.
  • Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315:362–71.
  • Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825–31.
  • Flejou JF. Barrett's oesophagus: from metaplasia to dysplasia and cancer. Gut 2005;54:i6–12.
  • Izzo JG, Luthra R, Wu TT, Correa AM, Luthra M, Anandasabapathy S, Molecular mechanisms in Barrett's metaplasia and its progression. Semin Oncol 2007;34:S2–6.
  • Razvi MH, Peng D, Dar AA, Powell SM, Frierson HF Jr, Moskaluk CA, Transcriptional oncogenomic hot spots in Barrett's adenocarcinomas: serial analysis of gene expression. Genes Chromosomes Cancer 2007;46:914–28.
  • van Bodegraven AA, Curley CR, Hunt KA, Monsuur AJ, Linskens RK, Onnie CM, Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology 2006;131:1768–74.
  • Sanchez E, Alizadeh BZ, Valdigem G, Ortego-Centeno N, Jimenez-Alonso J, de Ramon E, MYO9B gene polymorphisms are associated with autoimmune diseases in Spanish population. Hum Immunol 2007;68:610–15.
  • Nunez C, Oliver J, Mendoza JL, Gomez-Garcia M, Pinero A, Taxonera C, MYO9B polymorphisms in patients with inflammatory bowel disease. Gut 2007;56:1321–2.
  • Cooney R, Cummings JR, Pathan S, Beckly J, Geremia A, Hancock L, Association between genetic variants in myosin IXB and Crohn's disease. Inflamm Bowel Dis 2009;15:1014–21.
  • Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, Haplotype tagging for the identification of common disease genes. Nat Genet 2001;29:233–7.
  • A haplotype map of the human genome. International HapMap Consortium. Nature 2005;437:1299–320.
  • Monsuur AJ, de Bakker PI, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E, Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005;37:1341–4.
  • Hunt KA, Monsuur AJ, McArdle WL, Kumar PJ, Travis SP, Walters JR, Lack of association of MYO9B genetic variants with coeliac disease in a British cohort. Gut 2006;55:969–72.
  • Amundsen SS, Monsuur AJ, Wapenaar MC, Lie BA, Ek J, Gudjonsdottir AH, Association analysis of MYO9B gene polymorphisms with celiac disease in a Swedish/Norwegian cohort. Hum Immunol 2006;67:341–5.
  • Cirillo G, Di Domenico MR, Corsi I, Gagliardo T, Del Giudice EM, Perrone L, Do MYO9B genetic variants predispose to coeliac disease? An association study in a cohort of South Italian children. Dig Liver Dis 2007;39:228–31.
  • Giordano M, Marano C, Mellai M, Limongelli MG, Bolognesi E, Clerget-Darpoux F, A family-based study does not confirm the association of MYO9B with celiac disease in the Italian population. Genes Immun 2006;7:606–8.
  • Hanley PJ, Xu Y, Kronlage M, Grobe K, Schon P, Song J, Motorized RhoGAP myosin IXb (Myo9b) controls cell shape and motility. Proc Natl Acad Sci USA 2010;107:12145–50.
  • Wirth JA, Jensen KA, Post PL, Bement WM, Mooseker MS. Human myosin-IXb, an unconventional myosin with a chimerin-like rho/rac GTPase-activating protein domain in its tail. J Cell Sci 1996;109:653–61.
  • Wapenaar MC, Monsuur AJ, van Bodegraven AA, Weersma RK, Bevova MR, Linskens RK, Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut 2008;57:463–7.
  • Meddings J. The significance of the gut barrier in disease. Gut 2008;57:438–40.
  • Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spaces: a morphological feature of acid reflux–damaged human esophageal epithelium. Gastroenterology 1996;111:1200–5.
  • Bronstein M, Pisante A, Yakir B, Darvasi A. Type 2 diabetes susceptibility loci in the Ashkenazi Jewish population. Hum Genet 2008;124:101–4.
  • Menke V, van Zoest KP, Moons LM, Pot RG, van Dekken H, Hansen BE, 583 MYO9B polymorphisms and expression as predictors for the risk of Barrett's esophagus and esophageal adenocarcinoma in reflux patients. Gastroenterology 2008;134:A–79.
  • Latiano A, Palmieri O, Valvano MR, D'Inca R, Caprilli R, Cucchiara S, The association of MYO9B gene in Italian patients with inflammatory bowel diseases. Aliment Pharmacol Ther 2008;27:241–8.
  • Persengiev S, Koeleman BP, Downes K, Valdigem G, van der Slik AR, Eerligh P, Association analysis of myosin IXB and type 1 diabetes. Hum Immunol 2010;71:598–601.
  • Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001;2:91–9.
  • Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997;26:487–94.
  • van Blankenstein M, Looman CW, Johnston BJ, Caygill CP. Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy center. Am J Gastroenterol 2005;100:568–76.
  • Wong A, Fitzgerald RC. Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol 2005;3:1–10.
  • The International HapMap Consortium. Nature 2003;426:789–96.
  • Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM, Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000;66:1863–70.
  • Mullin JM, Valenzano MC, Trembeth S, Allegretti PD, Verrecchio JJ, Schmidt JD, Transepithelial leak in Barrett's esophagus. Dig Dis Sci 2006;51:2326–36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.